FDA announces comprehensive regenerative medicine policy framework

FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm585345.htm

Source: Food and Drug Administration - November 16, 2017 Category: American Health Source Type: news

More News: American Health | Food and Drug Administration (FDA)